In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases.

Due to the Memorial Day holiday (recognized on Monday, May 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the following plans for Domestic and International shipping:

Register now – July 8, 2025: PACE / State of FL - This webinar will discuss a range of critical topics essential for laboratory billing, coding, and compliance. Key areas of focus will include understanding and navigating National Correct Coding Initiative (NCCI) edits, reviewing newly released CPT codes, exploring important updates from Medicare Manuals, and discussing the process for submitting LCD Reconsideration Requests. Additionally, we will share insights into the latest priorities outlined in the OIG Workplan, helping organizations stay informed and aligned with federal expectations.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI).

The third episode of “Life of a Specimen” video series discusses the integration that drives the development of innovative tests, including the movement disorders evaluation, at Mayo Clinic Laboratories.

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Ellen Dijkman Dulkes and Brianne Newton. They discuss strategies for delivering excellent customer service.

Check out the second episode of “Life of a Specimen,” a video exploration of the complex path taken by patient samples through testing at Mayo Clinic Laboratories. In this episode, we hear about the quality processes and careful treatment given to each sample received for testing.

Due to weather affecting the FedEx hub in Memphis, TN, FedEx has initiated its contingency plan and expects delays. Mayo Clinic Laboratories’ Global Logistics team will proactivelymove work from FedEx to other commercial shipping options.

Excellent customer service flows from three foundational elements: organizational alignment, engaged employees, and the right systems and facilities.

Mayo Clinic Laboratories is monitoring and tracking back-to-back winter storms moving through the Midwest and East Coast to minimize challenges. Engagement with our logistics partners is underway to minimize challenges. If any routes are modified or canceled, clients in the affected areas will be contacted directly.

PACEThis webinar will provide a review of several real-life laboratory safety events. The presentation will outline the scenarios, the lessons learned and look at ways future incidents can be prevented. We will also discuss ways to create effective corrective and preventive action plans.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, for a conversation about quality management.

Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on one extraordinary patient.

Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares insights on balancing needs with future-oriented investments.

An order-entry, clinical decision support tool developed by physicians and scientists at Froedtert and the Medical College of Wisconsin (MCW) for clinicians within the healthcare system who order autoimmune and paraneoplastic antibody panels has significantly improved test utilization, resulting in a 28% reduction in monthly test volumes of impacted tests.